| Product Code: ETC6508333 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Brazil continued to heavily rely on imports of leflunomide, with top exporting countries being China, India, USA, Switzerland, and Metropolitan France. The High Herfindahl-Hirschman Index (HHI) indicates a market concentration among these exporters. Despite a negative Compound Annual Growth Rate (CAGR) of -2.64% from 2020 to 2024, the minor decline in growth rate from 2023 to 2024 suggests a relatively stable market for leflunomide imports in Brazil. Continued monitoring of market dynamics and potential diversification of import sources may be beneficial for the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brazil Leflunomide Market Overview |
3.1 Brazil Country Macro Economic Indicators |
3.2 Brazil Leflunomide Market Revenues & Volume, 2021 & 2031F |
3.3 Brazil Leflunomide Market - Industry Life Cycle |
3.4 Brazil Leflunomide Market - Porter's Five Forces |
3.5 Brazil Leflunomide Market Revenues & Volume Share, By Trade Names, 2021 & 2031F |
3.6 Brazil Leflunomide Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Brazil Leflunomide Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Brazil |
4.2.2 Growing awareness and adoption of leflunomide as a treatment option |
4.2.3 Favorable government policies supporting the healthcare sector in Brazil |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Brazil |
4.3.2 Competition from alternative treatment options for autoimmune diseases in the market |
5 Brazil Leflunomide Market Trends |
6 Brazil Leflunomide Market, By Types |
6.1 Brazil Leflunomide Market, By Trade Names |
6.1.1 Overview and Analysis |
6.1.2 Brazil Leflunomide Market Revenues & Volume, By Trade Names, 2021- 2031F |
6.1.3 Brazil Leflunomide Market Revenues & Volume, By Arava, 2021- 2031F |
6.1.4 Brazil Leflunomide Market Revenues & Volume, By Lefumide, 2021- 2031F |
6.1.5 Brazil Leflunomide Market Revenues & Volume, By Arabloc, 2021- 2031F |
6.1.6 Brazil Leflunomide Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Brazil Leflunomide Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Brazil Leflunomide Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.3 Brazil Leflunomide Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.2.4 Brazil Leflunomide Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Brazil Leflunomide Market Import-Export Trade Statistics |
7.1 Brazil Leflunomide Market Export to Major Countries |
7.2 Brazil Leflunomide Market Imports from Major Countries |
8 Brazil Leflunomide Market Key Performance Indicators |
8.1 Patient adherence rate to leflunomide treatment |
8.2 Number of healthcare providers prescribing leflunomide |
8.3 Rate of new clinical trials and research studies on leflunomide in Brazil |
9 Brazil Leflunomide Market - Opportunity Assessment |
9.1 Brazil Leflunomide Market Opportunity Assessment, By Trade Names, 2021 & 2031F |
9.2 Brazil Leflunomide Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Brazil Leflunomide Market - Competitive Landscape |
10.1 Brazil Leflunomide Market Revenue Share, By Companies, 2024 |
10.2 Brazil Leflunomide Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |